Activation-induced cytidine deaminase (AID) initiates immunoglobulin gene somatic hypermutation, gene conversion and class switch recombination (CSR) by inflicting DNA lesions at specific genomic loci via DNA cytosine deamination (that converts cytosine to uracil). While these lesions are essential for the production of optimized antibodies against infections, they are also threats to the genome integrity. AID-associated oncogenic mutations and chromosomal translocations are frequently seen in tumors of B cell origin. We propose three specific aims to address several significant gaps in our knowledge about the mechanism of CSR.
In aim 1, we will manipulate the transcription control elements (promoters/enhancers) at IgH ? locus in CH12F3 cells to identify cis-acting DNA elements critical for targeting AID to switch (S) regions.
In aim 2, we will determine the frequency and precise positions of AID footprints in S regions to delineate AID actions in vivo during CSR.
In aim 3, we will determine which DNA ligase is responsible for alternative end-joining of S region breaks.

Public Health Relevance

This proposed project focuses on elucidating the mechanism of a DNA recombination event through which cells in our immune system can produce the optimal antibody against infection. Studying the mechanism of this reaction and how it is regulated has a major impact on understanding the biology of DNA recombination, the pathology of a variety of immunological diseases and many forms of blood cancers.

Agency
National Institute of Health (NIH)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56AI081817-06
Application #
8891660
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Nasseri, M Faraz
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Michigan State University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
East Lansing
State
MI
Country
United States
Zip Code
48824